Formulation development for a zidovudine chemical delivery system 2. Towards oral and non-parenteral dosage forms
- 1 October 1995
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 125 (1) , 31-43
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Formulation development for a zidovudine chemical delivery system 1. Parenteral dosage formsInternational Journal of Pharmaceutics, 1995
- The Effect of Dihydronicotinate N-Substitution on the Brain-Targeting Efficacy of a Zidovudine Chemical Delivery SystemPharmaceutical Research, 1993
- Brain, Blood, and Cerebrospinal Fluid Distribution of a Zidovudine Chemical Delivery System in RabbitsJournal of Pharmaceutical Sciences, 1991
- Brain targeting of anti-HIV nucleosides: synthesis and in vitro and in vivo studies of dihydropyridine derivatives of 3'-azido-2',3'-dideoxyuridine and 3'-azido-3'-deoxythymidineJournal of Medicinal Chemistry, 1990
- An intravenous toxicity study of 2-hydroxypropyl-β-cyclodextrin, a useful drug solubilizer, in rats and monkeys☆International Journal of Pharmaceutics, 1990
- Pump delivery of azidothymidine: Potential for constant concentrations and improved brain deliveryJournal of Controlled Release, 1989
- Mechanism of drug dissolution rate enhancement from β-cyclodextrin-drug systemsJournal of Pharmacy and Pharmacology, 1982
- Rectal Drug AdministrationClinical Pharmacokinetics, 1982
- Site-Specific, Sustained Release of Drugs to the BrainScience, 1981
- Acid-Catalyzed Addition of Water to 1,4-Dihydronicotinamide Derivatives*Biochemistry, 1963